Evaluation on rational use of 5554 cases of asarone for injection
DANG An-jian
YU Qian
LI Xin
Abstract：Objective: To review the use of asarone for injection in China-Japan Union Hospital of Jilin University from January to August in 2016, and summarize the regularity and characteristics of ADR/ADE, in order to provide reference for clinical rational drug use. Methods: The retrospective study was carried out on 5554 cases of asarone for injection from January to August in 2016. The indications, dosage, frequency of drug administration, route of administration, solvent, etc. At the same time, the ADR/ADE report reported to the National Center for ADR Monitoring during this period were analyzed. The incidence of ADR/ADE induced by asarone for injection in 26 patients were analyzed statistically from the patients' medication, the occurrence time of ADR, the main clinical manifestations and other aspects. Results: There were 2918 cases (52.54%) without indications, the dose was not appropriate for 1059 cases (19.07%), treatment administration frequency was not suitable for 1765 cases (31.78%), the route of administration was not suitable for 319 cases (5.74%), etc. In 26 cases ADR/ADE of asarone for injection from January to August in 2016, there were 25 cases (96.15%) with no indications of medication, 23 cases (88.46%) without following the instructions to select the solvent and the solvent volume, 6 cases (23.08%) without in accordance with the instructions recommended dosage and frequency. Conclusion: The use of asarone for injection should be in strict accordance with the provisions of the drug instructions, the unreasonable use of drugs is the main reason for the occurrence of ADR/ADE.
Keywords：Asarone for injectionAdverse drug reactionEvaluationRational drug use
Publication Date：2017-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：3( 121-123 )